“…A). Many of these interaction nodes are associated with adverse health phenotypes: CUX1 repairs DNA oxidative damage and is a tumour suppressor , REL and NFKB2 are part of the NFKB signalling pathway and associated with immune function and cancer ; REST is a transcriptional repressor linked with prostate cancer and regulates cardiac gene expression ; EP300 is a transcriptional co‐activator that regulates circadian gene expression and ESR1‐stimulated expression and is linked with prostate cancer ; IL6, and MAPK11 are linked with immune function and cancer ; PIK3CA and PIK3R1 are linked with insulin resistance, immune response and cancer , PPARA is associated with lipid homeostasis, inflammation, and type‐2 diabetes , MLL is a methyltransferase that regulates circadian gene expression and is linked with cancer , and ESR1 regulates gene expression and is associated with cancer . An overlapping set of interacting genes are affected by both sleep restriction and mistimed sleep: MLL, CSNK1ε, MAP kinase transcripts (MAPK11, MAPK12, MAPK13), HSPA5, REST, NCOR1, IL6, MED1, and RORA.…”